TGTX
TG Therapeutics Inc
NASDAQ: TGTX · HEALTHCARE · BIOTECHNOLOGY
$33.58
-2.89% today
Updated 2026-04-29
Market cap
$5.36B
P/E ratio
12.12
P/S ratio
8.70x
EPS (TTM)
$2.77
Dividend yield
—
52W range
$25 – $46
Volume
2.0M
TG Therapeutics Inc (TGTX) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$33.58
12-Month target
$30.20
2030 Target
—
Intrinsic (DCF)
$16.56
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.2B | $0.3B | $0.6B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 12.12x (capped 25x) · Margin: 72.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.